Nabriva Therapeutics PLC – ADR (NASDAQ:NBRV): Samuel Isaly’s OrbiMed Advisors filed an amended 13D.
You can check out OrbiMed Advisors’ latest holdings and filings here.
Please follow OrbiMed Advisors (if you aren’t already doing so) to get real-time email alerts whenever we publish an article about OrbiMed Advisors or update its stock holdings.
You can access the original SEC filing by clicking here.
Ownership Summary Table
|Name||Sole Voting Power||Shared Voting Power||Sole Dispositive Power||Shared Dispositive Power||Aggregate Amount Owned Power||Percent of Class|
|OrbiMed Capital GP V||0||3,919,600||0||3,919,600||3,919,600||14.6%|
Page 1 of 6 – SEC Filing
OrbiMed Advisors LLC